#digital pharmacy market growth

[farhan1012]

Digital Pharmacy Market Size, Share, Growth Drivers, Trends and Forecast Report 2024-2034

The Digital Pharmacy market report offered by Reports Intellect is meant to serve as a helpful means to evaluate the market together with an exhaustive scrutiny and crystal-clear statistics linked to this market. The report consists of the drivers and restraints of the Digital Pharmacy Market accompanied by their impact on the demand over the forecast period. Additionally, the report includes the study of prospects available in the market on a global level. With tables and figures helping evaluate the Global Digital Pharmacy market, this research offers key statistics on the state of the industry and is a beneficial source of guidance and direction for companies and entities interested in the market. This report comes along with an additional Excel data-sheet suite taking quantitative data from all numeric forecasts offered in the study.

Get Sample PDF Brochure @ https://www.reportsintellect.com/sample-request/2740007

Key players offered in the market: CVS Health Cigna Optum Walgreen Co. Walmart Inc. The Kroger Co. Amazon GoodRx Costco Wholesale Corporation Rite Aid Corp. Hims & Hers Health PharmEasy Apollo Pharmacy

Additionally, it takes account of the prominent players of the Digital Pharmacy market with insights including market share, product specifications, key strategies, contact details, and company profiles. Similarly, the report involves the market computed CAGR of the market created on previous records regarding the market and existing market trends accompanied by future developments. It also divulges the future impact of enforcing regulations and policies on the expansion of the Digital Pharmacy Market.

Scope and Segmentation of the Digital Pharmacy Market

The estimates for all segments including type and application/end-user have been provided on a regional basis for the forecast period from 2024 to 2034. We have applied a mix of bottom-up and top-down methods for market estimation, analyzing the crucial regional markets, dynamics, and trends for numerous applications. Moreover, the fastest & slowest growing market segments are pointed out in the study to give out significant insights into each core element of the market.

Digital Pharmacy Market Type Coverage: - Apps Websites

Digital Pharmacy Market Application Coverage: - Urban Areas Rural Areas

Regional Analysis:

North America Country (United States, Canada) South America Asia Country (China, Japan, India, Korea) Europe Country (Germany, UK, France, Italy) Other Countries (Middle East, Africa, GCC)

Also, Get an updated forecast from 2024 to 2034.

Discount PDF Brochure @ https://www.reportsintellect.com/discount-request/2740007

The comprehensive report provides:

Reasons to Purchase Digital Pharmacy Market Research Report

Covid-19 Impact Analysis: Our research analysts are highly focused on the Digital Pharmacy Market covid-19 impact analysis. A whole chapter is dedicated to the covid-19 outbreak so that our clients get whole and sole details about the market ups & downs. With the help of our report the clients will get vast statistics as to when and where should they invest in the industry.

About Us: Reports Intellect is your one-stop solution for everything related to market research and market intelligence. We understand the importance of market intelligence and its need in today's competitive world.

Our professional team works hard to fetch the most authentic research reports backed with impeccable data figures which guarantee outstanding results every time for you.

Contact Us: sales@reportsintellect.com Phone No: + 1-706-996-2486 US Address: 225 Peachtree Street NE, Suite 400, Atlanta, GA 30303

[delvenservices]

Digital Pharmacy Market Trends & Forecast Report

This Digital Pharmacy Market report will Increase your understanding of the market for identifying the best and most suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends, and factors. Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future.

Get free sample report: https://www.delvens.com/get-free-sample/digital-pharmacy-market-trends-forecast-till-2030

Delvens Industry Expert's Standpoint:

The National Institute of Health (NIH) research states that buying goods and services online, including prescription drugs, has become standard practice with community pharmacies increasingly implementing digital health strategies. An increase in internet users, easier access to the internet and online services, and an increase in the use of digital prescriptions in hospitals and other healthcare facilities are all factors contributing to the growth of the digital pharmacy market. Doctors are now available with just a few clicks of your mouse making it easier for patients to get proper care and consultancy for their health problems.

Inquire before buying the complete report: https://www.delvens.com/Inquire-before-buying/digital-pharmacy-market-trends-forecast-till-2030

Key Findings

Digital Pharmacy is a digital platform also known as internet pharmacy or online pharmacy, involved in the sales of drugs, or medication to consumers. The platform is designed to provide online pharmacy services, including drug delivery. Digital Pharmacy allows prescription refilling and delivery over the counter as well as specialty medicines to patients.  

Significant increase in the number of online service providers has enhanced the accessibility to internet pharmacies in developing nations. In recent years, a considerable increase in the number of internet users has further led to a high adoption rate. Therefore, ease of access to internet pharmacies through smartphones and the availability of a range of pharmaceutical products are major factors driving the growth of the Digital Pharmacy market.  

During COVID-19, the Digital Pharmacy business has witnessed significant growth across developing countries including India. Regional lockdowns and movement restrictions have led to the adoption of Digital Pharmacy mobile applications providing online medicine delivery services. Further, government initiatives supporting digital technologies to improve medicine access have positively impacted the Digital Pharmacy market growth. Therefore, several industry players operating in the Digital Pharmacy business experienced an increase in the number of application subscriptions amid the pandemic.  

The market is also divided into various regions such as North America, Europe, Asia-Pacific, South America, and Middle East and Africa. North America accounts for the largest share of the studied market. This can be primarily attributed to the more significant number of internet users and higher adoption of online services, which are expected to augment the market's growth over the forecast period.

Direct Purchase for the report: https://www.delvens.com/checkout/digital-pharmacy-market-trends-forecast-till-2030

According to the regional analysis: North America to Dominate the Market

North America accounts for the largest share of the studied market. This can be primarily attributed to the more significant number of internet users and higher adoption of online services, which are expected to augment the market's growth over the forecast period.

The Key Players of the market are:

The Kroger Co, The Walgreen Company, Express Scripts Holding, CVS Health, DocMorris, Giant Eagle, Wal-Mart Stores, OptumRx, PharmEasy, 1mg and Netmeds are the major players operating in Digital Pharmacy Market.

Recent Developments

In 2021, Walgreens Co. (US) launched nationwide contactless same-day delivery services (in under two hours) for more than 24,000 products.  

In 2021, Rite Aid Corp. (US) partnered with Uber to deliver Rite Aid products nationwide through Uber Eats, allowing customers to conveniently order and receive essential healthcare and grocery items directly to their homes.

Read trending reports of Healthcare Industry: https://www.delvens.com/industry/healthcare

About Us:

Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.

Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.

Contact Us:

UNIT NO. 2126, TOWER B,

21ST FLOOR ALPHATHUM

SECTOR 90 NOIDA 201305, IN

+44-20-8638-5055

SALES@DELVENS.COM

[vynzresearchindia]

Global Digital Pharmacy Market Size, Share and Demand Forecast to 2030

The Global Digital Pharmacy Market research report has been released by VynZ Research with several updates and analysis of market trends, share, size, demand, growth, challenges, opportunities and pre and post COVID-19 impacts.

Key Highlights of the Global Digital Pharmacy Market report

The projection period for this global market to grow is 2022-2030

The Global Digital Pharmacy Market size was valued USD 224.9 billion by 2030.

The market is projected to grow at a 18.5% CAGR by 2027

Covid-19 analysis and its impact on the market

Industry ecosystem to competitive landscape’s curial role in growth role

Challenges and opportunities to get boost from recent developments and technology advancement

Request to get the sample copy of the research: https://www.vynzresearch.com/healthcare/digital-pharmacy-market/request-sample

Market segment analysis

The Global Digital Pharmacy Market is segmented into these categories for this analysis: Drug Type, Product, Platform, Business Model, and Geography. This segmentation allows executives to plan their products and spending based on the expected growth rates of each area: -

By Drug Type (Prescription Medicines, OTC, and Products)

By Product (Medicine, Vitamins & Supplements, Personal Care, CVD, Oncology, and Diabetes)

By Platform (Apps & Websites)

By Business Model (Captive, Franchise, and Aggregator)

By Region (North America, Europe, Asia-Pacific (APAC), Rest of the World (RoW))

For more insight: https://www.vynzresearch.com/healthcare/digital-pharmacy-market

The Global Digital Pharmacy Market’s competitive viewpoint

This research is an invaluable resource for investors, shareholders, industry planners, and new and existing businesses trying to broaden their reach in the current Market scenario. While focusing on top companies and their corporate strategies, market presence, operating segmentation, aggressive outlook, geographical expansion, pricing and value structures, the study painstakingly takes into account the market analysis. The major market players are: -

Tata 1mg

Netmeds Marketplace Ltd.

Evernorth Health Inc.

CVS Health

The Kroger Co.

Walgreen Co.

Walmart

Giant Eagle, Inc.

Rowlands Pharmacy

Apollo Pharmacy

 

 

Reason to buy this report

The report is unbiased and it provides the deep insight of global market including competitive and geographical landscape.

The report enlightens the large patterns, causes, and impact factors globally and locally.

Insightful study drills-out the main players of the global market and, their sources of income, share of the market, and the current course of events.

It looks into significant developments such as extensions, agreements, new product launches, and acquisitions on the horizon.

Research the market's potential, preferred position, opportunity, difficulty, restrictions, and hazards on a global and regional level.

Request for your custom requirements: https://www.vynzresearch.com/healthcare/digital-pharmacy-market/customize-report

Customized research report

We offer clients specialized report services that take into account the main variables influencing the development of the worldwide Market. Feel free to call or drop your requirement to get the get customized research report. 

Explore more reports by VynZ Research

Beauty Devices Market: https://www.vynzresearch.com/healthcare/beauty-devices-market

Skincare Devices Market https://www.vynzresearch.com/healthcare/skincare-devices-market

Hybrid Operating Room Market: https://www.vynzresearch.com/healthcare/hybrid-operating-room-market

Femtech Market: https://www.vynzresearch.com/healthcare/femtech-market

Chatbots in Healthcare Market: https://www.vynzresearch.com/healthcare/chatbots-in-healthcare-market

Healthcare IoT Security Market: https://www.vynzresearch.com/healthcare/healthcare-iot-security-market

Home Healthcare Market: https://www.vynzresearch.com/healthcare/global-home-healthcare-market

Anti-Aging Market: https://www.vynzresearch.com/healthcare/anti-aging-market

Electronic Health Records (EHR) Market: https://www.vynzresearch.com/healthcare/electronic-health-records-ehr-market

Population Health Management Market: https://www.vynzresearch.com/healthcare/population-health-management-market

[a-shade-of-blue]

Masterlist of Vetted Fundraisers from the Palestinians who directly contacted me (15-18 August)

17 August

Ghada Ashraf ( @ghadaashrafsousi, @ghada-ashraf-sousi): Ghada is a French teacher. Her daughter Maria has not been able to get vaccinated and complete her treatment because of the genocide. They are trying to evacuate out of Gaza. (https://gofund.me/094016c9) (Vetted by association. @amalashuor (#175 on the verified fundraiser list by el-shab-hussein and nabulsi) has stated that Ghada is her friend, see post here for proof) (17 Aug: LOW FUNDS! Only €155 raised of €30,000 goal (9 donations!).)

Maria (@maria-gaza1): Maria is a pharmacy student from a family of 6. Their home has been destroyed and they are displaced. (https://gofund.me/b297b689)(vetted by association. She's a friend of @/wafaaresh (shared by 90-ghost) and @/mohiy-gaza (shared by 90-ghost). See post here for proof.)

Basel Ayyad (@basel1995s, basel-1995): Basel is 28 years old and from a family of 8. His daughter has suffered from a disease that impacts her growth and sight, and with the lack of medical resources in Gaza, her health is getting worse and she is gradually lodging her eyesight. They are tyring to evacuate out of Gaza and get her the treatment she needs. (https://gofund.me/0e9c79b3) (This campaign is vetted twice(!) by el-shab-hussein and is listed as #214 on the vetted fundraiser list by el-shab-hussein and nabulsi.)

Mohammed Aldeeb (@mohammedaldeeb): Mohammed is a medical professional specializing in emergency care who worked at the Al-Shifa Hospital for years. Both his home and the hospital have been destroyed. He is from a family of four. They have managed to evacuate and are now trying to cover their living expenses in Egypt. (https://gofund.me/8906146e) (vetted by el-shab-hussein and is #212 on the vetted fundraiser spreadsheet by el-shab-hussein and nabulsi.)

Tahani El-Shorbage & Wissam (@weesamshorbaji, @tahanibaby): Tahani studied chemistry and digital marketing and was an assistant professor at a uni that has now been destroyed. Tahani’s children have contracted hepatitis from water pollution. They are trying to evacuate out of Gaza. (https://gofund.me/de78bf6f) ( #112 on the verified fundraiser list vetted by el-shab-hussein and nabulsi. Also promoted by nabulsi here.) (Tahani’s IG: tahani_marketing)

16 August

Karam Al-Madhoun (@karamalmadhoun0): Karam is a 20 year old graphic design student. He is from a family of five. Their house has been destroyed and they are now displaced. They are trying to evacuate to Egypt. (https://gofund.me/903d0086) (#109 on the verified fundraiser list vetted by el-shab-hussein and nabulsi) (his IG: karam_almadhoun7)

Ahmed Abu Al-Rish (@ahmadresh): Ahmed is 19 years old and wishes to study photographic design but was unable to due to the genocide. He and his family’s house has been bombed and they are now displaced. They wish to escape from this genocide. (https://gofund.me/cecba331) (shared by 90-ghost. Ahmad has also been confirmed as @/mohiy-gaza's brother (see post here))

Ahmed Abu Omar (@ahmedabuomar, ): Ahmed and his wife has 3 children: Omar (11), Ibrahim (10) and Ahmed (4). They have been displaced and are trying to evacuate out of Gaza to Egypt. (https://gofund.me/a4e4c8d7) (Shared by apollos-olives, who states that @/ahmedabuomar is a friend of @/ahmedabuyamin (ahmedabuyamin's gfm is listed as #264 on the verified fundraiser list vetted by el-shab-hussein and nabulsi))

Ahed Al-Ankara (@aahed255): Ahed and his wife Maysoon have 3 children: Fatima (9), Iman (6), and Nour (1). Their have been displaced for more than 10 times. They are trying to evacuate out of Gaza. (https://gofund.me/1e35b377) (This campaign has been shared by @/mohammedalanqer, whose gfm is #174 on the verified fundraiser list vetted by el-shab-hussein and nabulsi) (16 Aug: LOW FUNDS! Only €215 raised of €40,000 goal (8 donations))

15 August

Hazem Khalil (@hazempalestine): Hazeem has not been able to see his family who live in Northern Gaza since 2018 due to the difficult situation there. Their home has been destroyed and he is trying to evacuate his family of 7 (including 2 children who are his younger siblings. (https://gofund.me/55f0129e) (vetted by el-shab-hussein. He is also a friend of Bilal-Salah0. Listed as #281 on the verified fundraiser list by el-shab-hussein and nabulsi.)

Lina Zeyad (@lina-zeyad): Lina is an attorney and has 3 sons -  Abdullah, Yazan, Youssef, and a daughter who is married and pregnant. Her youngest son Yousseff has contracted Hepatitis C after having to drink contaminated water. (https://gofund.me/de10f8c6) (vetted by nabulsi.)

Amna Marwan (@gazaway13): Amna is a mother of 3 children: Ahmed(8), Adam (6), and Ayla (4). Their home has been destroyed and they are displaced. They are trying to evacuate out of Gaza. (https://gofund.me/36e10d4b) (#247 on the verified fundraiser list vetted by el-shab-hussein and nabulsi.)

Abdallah Mousa (@abdallahblog0): Abdallah is a 20 years old uni student. He dreams of becoming a doctor. His house and university has been destroyed. He and his family are trying to evacuate out of Gaza. (https://gogetfunding.com/your-help-is-the-only-hope-to-save-abdallah-his-family-from-genocide/) (https://www.paypal.com/paypalme/RawanMous) (shared by 90-ghost.)

Mahmoud Ziad (@mahmoud-ziad): Mahmoud is 24 years old. He has been displaced with elderly mother and father, his brothers, and his brother’s wife. (https://gofund.me/0aaeecea) (shared by 90-ghost)

Abood and Maria (@maria-abood, @abood-gaza2, @maria-abood2): Abood and Maria got married 5 months ago during the war. Maria is currently pregnant. They have been displaced more than 10 times. They are trying to evacuate out of Gaza. (https://gofund.me/7a4d8d0a) (vetted by association. (Maria's husband Abood is the brother of @/mohiy-gaza. See post here. Mohi's gfm has been shared by 90-ghost.))

Ahmed Khader (@ahmedpalestine): Ahmed is in Belgium but his family is still in Gaza. He is trying to evacuate his family of 12, including 8 adults and 4 children under 16 years old. (https://gofund.me/42d81684) (Ahmed's campaign is promoted by Bilal-Salah0. Bilal's campaign is listed as #132 on the verified fundraiser spreadsheet vetted by el-shab-hussein and nabulsi. Bilal's campaign has reached its goal and he has said that he will ensure the legitimacy of the campaigns he promotes (see post here).)

Ayaa Mahmoud (@ayoosh-gaza, her brother:@ahmad-gaza): Ayaa is a 24 years old children’s teacher . She is living with her parents and her 8 siblings. Their home has been destroyed and they are trying to evacuate to Egypt. (https://gofund.me/87a0fa9f) (Vetted by association. Ayaa is the sister-in-law of @eslamfamily (shared by @/90-ghost, #175 on the Bees and Watermelons spreadsheet). See post here for proof. Here's her IG: ayaa_mahmoud_99.))

Click here for my Masterlist for fundraisers from 13 July - 25 July.

Click here for my Masterlist for fundraisers from 26 July -29 July.

Click here for my Masterlist for fundraisers from 30 July - 1 August.

Click here for my Masterlist for fundraisers from 2 August - 5 August.

Click here for my Masterlist for fundraisers from 6 August - 10 August.

Click here for my Masterlist for fundraisers from 11 August - 14 August.

[beardedmrbean]

GERB unveiled its management program, with party leader Boyko Borisov expressing readiness to negotiate with any party that acknowledges GERB's agenda after the June 9 elections. During the event, Borissov emphasized that the political crisis should be resolved with a comprehensive management mandate and a prominent political leader heading the cabinet.

Raya Nazaryan, the deputy chairperson of the GERB parliamentary group, described Borissov as the "brightest political figure," implying his candidacy for prime minister. This message is a key component of GERB's pre-election campaign, alongside the need to end "unsuccessful experiments," as stated by Tomislav Donchev. He reiterated that the leading political force would establish a government.

The management program highlights four factors for effective governance:

Ending the political crisis with a full management mandate

Establishing a government with political accountability

Ensuring reconciliation, stability, and consistent effort

Providing authentic leadership capable of making sound decisions

GERB's program focuses on six main areas: education and labor market, healthcare, modernization and digitalization, industrialization and infrastructure, security and defense, and legal reform.

Former Education Minister Krasimir Valchev declared education as the main priority, emphasizing the need for a long-term commitment. Key proposals include promoting dual education, funding student internships, and increasing student classes in businesses. Valchev stressed the importance of long-term parliaments to implement these reforms.

Other educational priorities include raising salaries for teachers and university professors above the national average, expanding nursery and kindergarten places, and renovating educational facilities.

In healthcare, GERB plans to establish a National Center for screening and preventing significant diseases, create a new National Program for transplants, and introduce telemedicine, mobile medical teams, and mobile pharmacies.

With a full four-year mandate, GERB promises full membership in Schengen, the Eurozone, and the OECD, GDP growth to 120 billion euros, and income growth to 75-80% of the European average. They propose a new Public-Private Partnership Law, 15 industrial parks, and easier land expropriation processes.

In digitization, GERB advocates for a digital identity law to replace electronic signatures, improved e-ticket sales services, and using artificial intelligence to address traffic congestion.

GERB also aims to introduce the concept of "water poverty," support for those in need, improve water quality, and encourage investments in renewable energy installations.

In legal reform, GERB pledges to continue anti-corruption efforts, adopt a new Penal Code, and introduce more restrictions for young drivers.

At the end of the program presentation, Boyko Borissov noted that the plans would remain unimplemented without clear governance partners. Although he didn't specify potential partners, DPS chairman Delyan Peevski later discouraged Borissov from planning to govern with "We Continue the Change," accusing them of financial misconduct.

Borissov criticized his former partners from "We Continue the Change - Democratic Bulgaria," accusing them of seeking new elections in the fall. He called for post-election unity among parties to advance the country's development, warning against continued political fragmentation.

[rajdhami01-blog]

Emerging Trends in Pharmaceutical Education 

Pharmaceutical education is experiencing a transformative shift in response to rapid advancements in the field of healthcare and the evolving needs of the global population. As we step into a future characterised by personalised medicine, precision therapies, and breakthrough technologies, the training and education of future pharmacists and pharmaceutical professionals are adapting to keep pace. In this blog, we will bring forth the latest developments and emerging trends in pharmaceutical education. 

According to Statista Pharmaceutical Market Forecast, the pharmaceutical industry has witnessed a rapid metamorphosis, with revenue expected to show an annual growth rate (CAGR 2023-2028) of 5.80%, resulting in a market volume of US$1,478.00bn by 2028, reflecting the sector's exponential growth. This growth is propelled by various factors, including an aging population, the rise of chronic diseases, and the increasing demand for personalised treatments. In response, pharmaceutical education is adapting to equip aspiring pharmacists and professionals with the skills and knowledge needed to navigate this dynamic and ever-evolving industry. 

1. Integration of Technology and Digital Learning 

In recent years, the integration of technology into pharmaceutical education has become ubiquitous. Digital platforms, virtual labs, simulation software, and online courses are revolutionizing the way students learn and engage with the subject matter. Augmented Reality (AR) and Virtual Reality (VR) are being utilized to create immersive learning experiences, allowing students to visualize complex pharmaceutical concepts in a more interactive and dynamic manner. These technologies enhance understanding and retention, ultimately preparing students for the technologically advanced landscape of modern healthcare. 

2. Focus on Interdisciplinary Learning 

Pharmaceutical education is embracing an interdisciplinary approach, fostering collaboration between pharmacy students and professionals from other healthcare domains. Interdisciplinary learning encourages a holistic understanding of healthcare systems and enables students to work seamlessly in a team-based environment. Collaborations with medical practitioners, bioinformatics experts, data scientists, and engineers expose students to diverse perspectives and problem-solving strategies, preparing them to be well-rounded professionals in an interdisciplinary healthcare landscape. 

3. Personalised and Individualised Learning 

Recognizing the unique learning styles and paces of individual students, personalized learning is gaining traction in pharmaceutical education. Tailoring educational experiences to meet the specific needs and preferences of students allows for a more effective learning process. Adaptive learning technologies use data analytics to track student progress and adapt the content and pace of learning accordingly. This approach optimizes comprehension and retention, ensuring that each student achieves their educational goals. 

4. Integration of Pharmacogenomics and Genetics 

Advancements in pharmacogenomics and genetics are transforming pharmaceutical education by necessitating a deeper understanding of how genetic variations influence drug responses. Modern curricula are incorporating in-depth studies of genomics, pharmacogenomics, and genetic testing to equip future pharmacists with the knowledge and skills to provide personalized medication recommendations based on an individual's genetic makeup. This personalized approach improves patient outcomes and reduces adverse reactions. 

5. Emphasis on Soft Skills and Professionalism 

Pharmaceutical education is evolving to place greater emphasis on soft skills and professionalism. Effective communication, leadership, critical thinking, and empathy are essential qualities for pharmaceutical professionals. Educational programs now integrate courses and workshops that enhance these skills, preparing students not only to excel in their technical roles but also to effectively interact with patients, colleagues, and healthcare stakeholders. 

6. Experiential Learning and Practical Exposure 

Traditional classroom-based learning is being complemented with experiential learning and practical exposure in real-world healthcare settings. Internships, externships, and rotations in community pharmacies, hospitals, research laboratories, and pharmaceutical industries provide students with valuable hands-on experience. These opportunities bridge the gap between theory and practice, enabling students to apply their knowledge in real-life scenarios and develop the necessary skills and confidence for their future careers. 

7. Environmental and Global Health Perspectives 

As sustainability and global health become paramount concerns, pharmaceutical education is incorporating curricula that address the environmental impact of pharmaceuticals and global health challenges. Students are exposed to the concepts of eco-friendly pharmaceutical practices, responsible drug manufacturing, and the role of pharmacists in addressing global health issues. This broadens their understanding of the industry's impact on the planet and society, encouraging responsible and ethical practices. 

Pioneering Pharmaceutical Education in India 

Shoolini University stands at the forefront of innovative pharmaceutical education in India. Renowned for its commitment to academic excellence, state-of-the-art infrastructure, and emphasis on holistic development, Shoolini University has emerged as a top choice for students aspiring to excel in the pharmaceutical field. Let's delve into the details of the pharmaceutical education offerings and the esteemed Faculty of Pharmaceutical Sciences at Shoolini University. 

Here are some highlights of Shoolini University's exceptional pharmaceutical education: 

Faculty from prestigious institutions worldwide, including University of Innsbruck (Austria), University of Constance (Germany), Chang Won National University (South Korea), and NIPER. 

Pharma NIRF Rank 41 (All India), reflecting the university's academic prowess and standing in the pharmaceutical education landscape. 

The Faculty of Pharmaceutical Sciences boasts 104+ cutting-edge laboratories across the university, providing students with extensive practical exposure and fostering research and innovation. 

Students receive scholarships and fellowships at both undergraduate (UG) and postgraduate (PG) levels, encouraging academic excellence and reducing the financial burden on students. 

An application-oriented curriculum that prepares students for real-world challenges, ensuring they are industry-ready upon graduation. 

Programs Offered by Shoolini University

Program 1

B Pharmacy 

Duration : 4 years 

Eligibility : 10+2 (PCB/PCM) with minimum 60% marks 

Program 2

B Pharmacy LEET 

Duration : 3 years 

Eligibility : Diploma in Pharmacy with 60% marks from a Pharmacy Council of India approved institution 

Program 3

M Pharma Pharmacology 

Duration : 2 years 

Eligibility : B Pharmacy from an institution approved by the Pharmacy Council of India with minimum 55% marks 

Program 4

M Pharmacy Pharmaceutical Chemistry 

Duration : 2 years 

Eligibility : B Pharmacy from an institution approved by the Pharmacy Council of India with minimum 55% marks 

Program 5

M Pharmacy Pharmaceutics 

Duration : 2 years 

Eligibility : B Pharmacy from an institution approved by the Pharmacy Council of India with minimum 55% marks 

Program 6

PhD Pharma 

Duration : 3 years 

Eligibility : Four-year graduation degree by research or master's degree in related discipline with minimum 55% marks 

In conclusion, Shoolini University is leading the way in pharmaceutical education in India, aligning its programs with the evolving trends and demands of the healthcare industry. Through a focus on innovation, interdisciplinary learning, practical exposure, and a dedicated faculty, Shoolini University equips its students to contribute significantly to the advancement of pharmaceutical sciences and improve healthcare outcomes for individuals and communities. 

[health-views-updates]

2024 Compounding Pharmacies Market Dynamics: Trends and Insights

The global compounding pharmacies market is projected to witness steady growth over the next decade, with its market size expected to increase from USD 12.6 billion in 2023 to USD 19.9 billion by 2032. The market will experience a compound annual growth rate (CAGR) of 5.2% during the forecast period from 2024 to 2032, driven by rising demand for personalized medications and tailored healthcare solutions.

Compounding pharmacies provide customized medications by combining, altering, or mixing ingredients to meet individual patient needs. These pharmacies are particularly beneficial for patients who require specific doses, alternative forms of medication, or allergen-free formulations that are not available in mass-produced pharmaceutical products. As the healthcare landscape shifts toward more personalized approaches, the compounding pharmacy industry is poised for consistent growth.

Get Free Sample PDF: https://www.snsinsider.com/sample-request/4513 

Key Market Drivers

Rising Demand for Personalized Medication: One of the primary growth drivers for the compounding pharmacies market is the increasing demand for personalized healthcare. Standard pharmaceutical products do not always meet the specific needs of every patient. Compounding pharmacies play a crucial role in filling this gap by offering custom formulations that cater to individual patient requirements, such as adjusting medication strengths, flavors, or delivery methods. This trend is especially prevalent in treating chronic conditions, hormone replacement therapies, and pediatric care.

Growth of Geriatric Population: The global aging population is a significant factor contributing to the expansion of the compounding pharmacies market. Older adults often require personalized medication solutions due to polypharmacy (the use of multiple medications) and the need for tailored dosages. Many elderly patients also face difficulties in swallowing pills, leading to a demand for liquid formulations or transdermal options that compounding pharmacies can provide.

Increasing Incidence of Chronic Diseases: The rising prevalence of chronic diseases such as diabetes, cardiovascular diseases, and cancer has further propelled the need for customized therapies. Compounding pharmacies are able to develop medications that are tailored to manage the symptoms of these conditions effectively. In addition, they can create formulations that address medication shortages or provide alternative treatments when commercial drugs are unavailable.

Regulatory Support and Innovations: Regulatory bodies such as the U.S. Food and Drug Administration (FDA) are increasingly supporting the use of compounding pharmacies, provided they adhere to stringent quality standards. Regulatory initiatives, along with technological advancements in compounding techniques, are creating new opportunities for market growth. Innovations in drug delivery methods, automation, and formulation technologies are further enhancing the capabilities of compounding pharmacies to produce high-quality and safe medications.

Challenges and Market Opportunities

Despite the positive outlook, the compounding pharmacies market faces several challenges. Stringent regulatory frameworks and concerns over the safety and efficacy of compounded medications can hinder market growth. Compounding pharmacies must meet rigorous quality standards, and any lapses can affect public trust and demand for their services.

However, the increasing focus on patient-centric care, coupled with technological advancements in drug compounding, presents ample opportunities. Automation in compounding processes is reducing the risk of human error, while digital health solutions are making it easier for healthcare providers to prescribe customized medications. Additionally, the market is expected to see growth in veterinary compounding, as pet owners seek personalized treatments for their animals.

Regional Insights

North America remains the largest market for compounding pharmacies, driven by the presence of advanced healthcare infrastructure and a strong focus on personalized medicine. The United States, in particular, has a well-established regulatory framework that supports compounding pharmacies, leading to the proliferation of these services.

Europe is also witnessing steady growth, especially in countries like Germany, the UK, and France, where there is increasing awareness of the benefits of personalized medication. Meanwhile, the Asia-Pacific region is emerging as a key growth area due to its expanding healthcare sector, growing patient population, and increasing demand for customized treatments.

Future Outlook

The future of the compounding pharmacies market looks promising, as healthcare continues to move toward a more personalized and patient-centric model. With a projected CAGR of 5.2% from 2024 to 2032, the market is expected to see innovations in compounding technologies and broader adoption of custom medications across various therapeutic areas.

In conclusion, the global compounding pharmacies market, valued at USD 12.6 billion in 2023, is on track to reach USD 19.9 billion by 2032. With the rising demand for personalized medicine, the growth of the aging population, and advancements in compounding techniques, this market is set for significant expansion over the next decade.

Other Trending Reports

Dental Suction Systems Market

Cosmeceuticals Market

Cell Therapy Market

Growth Hormone Deficiency Market

[amrutatbrc1]

Refrigerated Warehousing And Storage Market 2024-2033 : Demand, Trend, Segmentation, Forecast, Overview And Top Companies 

The refrigerated warehousing and storage global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.

Refrigerated Warehousing And Storage Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.

Market Size - The refrigerated warehousing and storage market size has grown strongly in recent years. It will grow from $172.31 billion in 2023 to $187.87 billion in 2024 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to globalization of the food supply chain, consumer demand for fresh products, e-commerce and online grocery shopping, pharmaceutical supply chain requirements.

The refrigerated warehousing and storage market size is expected to see strong growth in the next few years. It will grow to $262.9 billion in 2028 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to population growth and urbanization, sustainability and energy efficiency, economic growth in emerging markets, climate change and extreme weather events. Major trends in the forecast period include technology integration, energy efficiency and sustainability, e-commerce and last-mile delivery, cold storage for e-pharmacies.

Order your report now for swift delivery @ https://www.thebusinessresearchcompany.com/report/refrigerated-warehousing-and-storage-global-market-report

The Business Research Company's reports encompass a wide range of information, including:

1. Market Size (Historic and Forecast): Analysis of the market's historical performance and projections for future growth.

2. Drivers: Examination of the key factors propelling market growth.

3. Trends: Identification of emerging trends and patterns shaping the market landscape.

4. Key Segments: Breakdown of the market into its primary segments and their respective performance.

5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.

6. Macro Economic Factors: Assessment of broader economic elements impacting the market.

Market Drivers - Warehouses are increasingly using mobile technologies to efficiently monitor warehouse operations. Mobile technology includes the use of tablets, smartphones, mobile printers, and other handheld devices for communication and information. These devices make use of GPS, RFID, VoIP, digital imaging, and voice technology. Technicians operating forklifts and automated material handling equipment in a warehouse are using mobile technologies to obtain information on troubleshooting, repairs, and work orders. This gives warehouse managers access to equipment status and performance reports and enables them to track warehouse operations around the clock. Wearable technology such as smart glasses is being integrated with warehouse management systems to improve hands-free mobility for workers. According to a report by MHI, a material handling, logistics, and supply chain association, 22% of the respondents use mobile technologies in warehouses, and the adoption rate is expected to reach 45% in the next two years.

The refrigerated warehousing and storage market covered in this report is segmented –

1) By Type: Cold Storage, Frozen Storage 2) By Ownership: Private Warehouses, Public Warehouses, Bonded Warehouses 3) By Application: Fruits and Vegetables, Bakery and Confectionery, Milk and Dairy Products, Meat, Seafood, Beverages, Other Applications

Get an inside scoop of the refrigerated warehousing and storage market, Request now for Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=2256&type=smp

Regional Insights - Asia-Pacific was the largest region in the refrigerated warehousing and storage market in 2023. North America was the second largest region in the refrigerated warehousing and storage market. The regions covered in the refrigerated warehousing and storage market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Key Companies - Major companies operating in the refrigerated warehousing and storage market include AmeriCold Logistics, Nichirei Corporation, Lineage Logistics Holdings LLC, Henningsen Cold Storage Co., Burris Logistics, Toyo Suisan Kaisha Ltd., Agro Merchants North America Holdings LLC, Nippon Suisan Kaisha Ltd., Snowman Logistics Ltd., Lineage Logistics, Americold Reality Trust Inc., United States Cold Storage Inc., NewCold Cooperatief U.A., Nichirei Logistics Group Inc., Emergent Cold LatAm Management LLC, Interstate Warehousing Inc., Frialsa Frigorificos S.A. De C.V., Constellation Cold Logistics, Superfrio Logistica Frigorificada, FreezPak Logistics, Conestoga Cold Storage Limited, Congebec Logistics Inc., METCOLD Supply Network Management Limited, RLS Logistics, Friozem Armazens Frigorificos Ltda., Magnavale Ltd., Confederation Freezers, Trenton Cold Storage Inc., Nor-Am Cold Storage, Burris Logistics, Agri-Norcold A/S, Vertical Cold Storage, ColdPoint Logistics, Hanson Logistics Ltd., Cloverleaf Cold Storage Co., Henningsen Cold Storage Co., Gruppo Marconi Logistica Integrata, Zero Mountain Inc.

Table of Contents 1. Executive Summary 2. Refrigerated Warehousing And Storage Market Report Structure 3. Refrigerated Warehousing And Storage Market Trends And Strategies 4. Refrigerated Warehousing And Storage Market – Macro Economic Scenario 5. Refrigerated Warehousing And Storage Market Size And Growth ….. 27. Refrigerated Warehousing And Storage Market Competitor Landscape And Company Profiles 28. Key Mergers And Acquisitions 29. Future Outlook and Potential Analysis 30. Appendix

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www

[colinwilson11]

Digitalization Will Propel The Bullous Pemphigoid Market Growth Owing To Increased Diagnosis Accuracy

The Bullous Pemphigoid Market involves treating a rare autoimmune disease wherein the immune system attacks the skin and mucous membranes resulting in large fluid-filled blisters and vesicles on the skin and mucosal membrane. Bullous Pemphigoid primarily affects the elderly population above the age of 60 and leads to extensive itching and pain. The main treatment modalities involve immunomodulatory medications such as corticosteroids, anti-inflammatory drugs, and immunosuppressive medications to ease symptoms.

The Bullous Pemphigoid Market is estimated to be valued at US$ 1.4 Bn in 2024 and is expected to exhibit a CAGR of 10% over the forecast period 2024-2031.

Key players operating in the Bullous Pemphigoid market are GlaxoSmithKline, Novartis, Pfizer, AstraZeneca, and Roche. These companies offer a range of treatment options from oral and topical corticosteroids to immunosuppressive therapies. The increasing geriatric population prone to developing bullous pemphigoid coupled with rising awareness regarding the condition is expected to drive the growth of the market. Additionally, advancements in diagnosis facilitated by digital imaging technologies assist in prompt diagnosis and treatment of the condition, thereby improving treatment outcomes.

Key Takeaways

Key players analysis: Key players operating in the Bullous Pemphigoid market are GlaxoSmithKline, Novartis, Pfizer, AstraZeneca, and Roche. GlaxoSmithKline leads the market with drugs including Rituximab and Benlysta.

Growing demand: The growing geriatric population accounted for a major share of the bullous pemphigoid patient pool. According to the WHO, the number of people aged 60 years and older is expected to double by 2050. This significantly drives the demand for bullous pemphigoid treatment.

Technological advancement: Advancements in digital imaging and teledermatology allow accurate diagnosis of bullous pemphigoid through visualization of skin lesions via smartphones and teleconsultation. This enables early intervention and superior management of the condition.

Market Trends

Combination therapies: There is a growing trend of using drug combinations as opposed to monotherapies to effectively manage bullous pemphigoid. Popular combinations involve corticosteroids with immunosuppressants.

Targeted biologic agents: Novel targeted biologic agents aimed at specific antibodies and immune pathways involved in bullous pemphigoid show promise. Drugs like Rituximab, Inebilizumab, and Eculizumab are being evaluated for efficacy and safety.

Market Opportunities

Emerging economies: Countries in Asia Pacific and Latin America present lucrative opportunities for bullous pemphigoid treatment providers owing to growing medical needs of their aging population and economic expansion.

Online consultations: Telehealth and e-pharmacy platforms allow people to remotely access bullous pemphigoid specialists and medication, thereby overcoming distance barriers. This increases access to care.

Impact Of COVID-19 On Bullous Pemphigoid Market Growth

The COVID-19 pandemic has significantly impacted the growth of the bullous pemphigoid market. During the initial phases of the pandemic between 2020-21, the market witnessed a decline in growth rate owing to lockdowns imposed across various countries. This led to postponement of non-essential dermatological procedures and treatments. Patients also avoided visiting healthcare facilities fearing exposure to the virus. As a result, diagnosis and treatment rates for bullous pemphigoid reduced considerably during this period.

However, with lifting of lockdowns and rollout of vaccination drives globally, the market has started recovering post 2021. Increased awareness about the autoimmune disorder and availability of effective treatment options are supporting the growth trajectory. Various initiatives undertaken by key market players to ensure uninterrupted supply of drugs and therapies have also boosted market revenues. For instance, companies streamlined their production and distribution channels to meet the rising demand. Teleconsultations further aided continued care for patients during lockdowns.

Going forward, the bullous pemphigoid market is expected to witness robust expansion supported by ageing population prone to developing the condition. Moreover, rapid advancements in biologics and targeted therapies will expand treatment options. Players are investing heavily in R&D to develop novel pipeline drugs. Favorable regulatory environment and reimbursement policies will augment market access. Widespread vaccination drives and resumption of normal healthcare activities will further accelerate market growth in the coming years.

Europe holds the largest share of bullous pemphigoid market in terms of value owing to sizeable patient pool and high treatment uptake. North America follows Europe in terms of revenue generation led by rising disease prevalence and advanced healthcare infrastructure. Asia Pacific is recognized as the fastest growing regional market and will continue exhibiting strong growth momentum through 2031. This can be attributed to improving access to diagnosis and treatment options due to expanding healthcare expenditure in countries like China and India.

Geographical Regions With Highest Bullous Pemphigoid Market Value

North America accounts for the largest share of the Bullous Pemphigoid Market value-wise. The region is estimated to hold over 35% revenue share of the overall market in 2024 led by strong presence of leading pharmaceutical companies in US and Canada. Increased focus on research into novel treatment options along with supportive reimbursement policies are driving the growth of the North America bullous pemphigoid market.

Europe holds the second largest value share globally on account of rising burden of the autoimmune disorder due to aging population. Countries like Germany, UK, France, Italy are major revenue generators for Europe bullous pemphigoid market. High healthcare expenditure and availability of affordable treatments make Europe an attractive regional market.

Geographical Region Witnessing Fastest Growth In Bullous Pemphigoid Market

Asia Pacific region has emerged as the fastest growing geographical market for bullous pemphigoid globally. The Asia Pacific bullous pemphigoid market is projected to expand at a CAGR of over 12% during 2024-2031. Factors such as growing geriatric demographic, increasing medical awareness regarding bullous pemphigoid diagnosis and management, rising healthcare spending, and improving access to advanced drugs are fueling the market growth. Countries like India, China, Japan, and South Korea are expected to drive substantial revenues for bullous pemphigoid treatment manufacturers within Asia Pacific market.

Get more insights on this topic:  https://www.ukwebwire.com/bullous-pemphigoid-market-growth-to-be-fueled-by-advancements-in-targeted-therapies/

Author Bio:

Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163 )

What Are The Key Data Covered In This Bullous Pemphigoid Market Report?

:- Market CAGR throughout the predicted period

:- Comprehensive information on the aspects that will drive the Bullous Pemphigoid Market's growth between 2024 and 2031.

:- Accurate calculation of the size of the Bullous Pemphigoid Market and its contribution to the market, with emphasis on the parent market

:- Realistic forecasts of future trends and changes in consumer behaviour

:- Bullous Pemphigoid Market Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa

:- A complete examination of the market's competitive landscape, as well as extensive information on vendors

:- Detailed examination of the factors that will impede the expansion of Bullous Pemphigoid Market vendors

FAQ’s

Q.1 What are the main factors influencing the Bullous Pemphigoid Market?

Q.2 Which companies are the major sources in this industry?

Q.3 What are the market’s opportunities, risks, and general structure?

Q.4 Which of the top Bullous Pemphigoid Market companies compare in terms of sales, revenue, and prices?

Q.5 Which businesses serve as the Bullous Pemphigoid Market’s distributors, traders, and dealers?

Q.6 How are market types and applications and deals, revenue, and value explored?

Q.7 What does a business area’s assessment of agreements, income, and value implicate?

*Note: 1. Source: Coherent Market Insights, Public sources, Desk research 2. We have leveraged AI tools to mine information and compile it

[namastenetindia]

Welcome to NamasteNet: Your Trusted Partner in Web Design and POS Software Solutions

At NamasteNet, we believe in the power of digital transformation for businesses of all sizes. Located in the heart of Hyderabad, we specialize in providing affordable web design and POS software solutions tailored specifically for Indian startups and small businesses.

Affordable Web Design That Elevates Your Business

NamasteNet offers custom website design services starting at just ₹4,999, making high-quality web design accessible to all. We don’t just build websites—we create digital experiences that reflect your brand's unique identity. Whether you're an emerging startup or an established business, our team ensures that your online presence stands out and delivers a seamless experience across all devices.

With a focus on responsive web design, we ensure that your website looks stunning whether viewed on a desktop, tablet, or smartphone. In today's mobile-first world, responsive design isn't just a feature—it's a necessity. And with our SEO-optimized websites, your business will not only look great but also rank higher in search engine results, driving organic traffic to your site.

Revolutionary POS Software to Streamline Your Operations

NamasteNet offers POS software starting at just ₹3,999, designed to streamline sales processes, enhance inventory management, and provide real-time business insights. Our cloud-based POS solutions are built to help retail stores, restaurants, and pharmacies run efficiently, without the hassle of paperwork or manual tracking.

Whether you’re a retailer in need of a reliable retail POS system or a restaurant seeking to improve customer service with a restaurant POS solution, NamasteNet’s software provides easy-to-use interfaces and robust functionality. With features like real-time sales tracking and inventory management, our POS systems will save you time and boost your bottom line.

Why NamasteNet?

NamasteNet prides itself on delivering Made-in-India solutions under the Digital India initiative. Our local expertise and understanding of the Indian market allow us to craft products that are not only affordable but highly effective for Indian businesses. We’re committed to supporting the growth of businesses with our affordable digital solutions that cater specifically to their needs.

Your Success is Our Success

We don’t just stop at providing the technology. The NamasteNet team is dedicated to offering unparalleled customer support and assistance every step of the way. Whether you need a complete digital overhaul or just a single service, we are here to help your business thrive in the digital age.

For businesses looking for an all-in-one solution to both their web design and POS software needs, NamasteNet is the partner you can trust. With affordable pricing and tailored solutions, we help businesses unlock their full digital potential.

Contact us today to learn more:

📞 +91 905 905 4355 📧 info@namastenet.com 🏢 16-11-220, East Prasanth Nagar, Moosarambagh, Hyderabad - 500036

[delistedshares]

Pharmeasy Unlisted Share Price: Key Factors Impacting Value

Investing in unlisted shares is an increasingly popular strategy among savvy investors looking to capture high-growth potential before a company goes public. Pharmeasy, one of India’s leading digital healthcare platforms, has garnered significant interest in the unlisted market. The Pharmeasy unlisted share price has attracted attention due to the company’s impressive growth trajectory, robust market position, and future potential. However, various factors impact the value of these shares. Understanding these factors is crucial for anyone considering an investment in Pharmeasy unlisted shares.

1. Company Performance and Financial Health

The fundamental factor influencing the Pharmeasy unlisted share price is the company's overall performance and financial health. Pharmeasy has shown strong growth, driven by its dominance in the online pharmacy sector and the broader healthcare market. The company's revenue growth, profitability, and expansion plans directly impact the demand for its unlisted shares.

Pharmeasy has consistently reported increasing revenues due to its broad customer base and diverse service offerings, including medicine delivery, telemedicine, and diagnostic services. Investors are particularly interested in companies that have demonstrated resilience and adaptability in the evolving healthcare landscape. A strong financial outlook boosts investor confidence and positively affects the Pharmeasy unlisted share price.

2. Industry Growth and Market Trends

Pharmeasy operates in the digital healthcare space, a sector that has seen exponential growth in recent years, especially in the wake of the COVID-19 pandemic. The pandemic highlighted the importance of accessible healthcare services, and digital health platforms like Pharmeasy have been at the forefront of meeting this demand.

The rapid digitization of healthcare services in India, along with increasing internet penetration and smartphone adoption, has created a favorable environment for companies like Pharmeasy to thrive. As the industry continues to grow, the Pharmeasy unlisted share price is likely to benefit from these positive market trends. Investors should keep a close eye on industry reports and market forecasts to gauge how external factors might influence the value of their unlisted shares.

3. Potential for an Initial Public Offering (IPO)

One of the most significant factors influencing the Pharmeasy unlisted share price is the potential for an Initial Public Offering (IPO). Many investors are drawn to unlisted shares with the anticipation that the company will eventually go public. When a company lists its shares on a recognized stock exchange, early investors often benefit from substantial gains, as the shares typically trade at a higher valuation post-IPO.

Pharmeasy has already gained considerable attention from private equity firms and venture capitalists, signaling strong investor confidence. If Pharmeasy decides to go public, the unlisted share price could see a significant appreciation as public investors rush to buy into the company. This potential for an IPO is a key driver of the current demand for Pharmeasy unlisted shares.

4. Strategic Partnerships and Acquisitions

Pharmeasy’s strategic partnerships and acquisitions play a critical role in shaping the company's future and, by extension, the Pharmeasy unlisted share price. The company has been actively expanding its capabilities by acquiring complementary businesses and forming strategic alliances.

For example, Pharmeasy’s acquisition of Medlife, one of its major competitors in the online pharmacy space, helped solidify its market leadership. Strategic moves like these enhance Pharmeasy’s operational efficiency, expand its customer base, and improve its product and service offerings. These developments positively impact the company’s valuation and, in turn, the Pharmeasy unlisted share price.

5. Regulatory Environment

The regulatory environment is another important factor that influences the Pharmeasy unlisted share price. The healthcare sector in India is subject to various regulations, especially concerning online pharmacies and telemedicine services. Any changes in government policies or regulations can directly impact Pharmeasy’s business operations and profitability.

For instance, stricter regulations on online medicine sales could potentially affect Pharmeasy’s revenue streams. On the other hand, government support for digital healthcare initiatives could create new growth opportunities for the company. Investors need to monitor regulatory developments closely, as they can have a direct impact on the Pharmeasy unlisted share price.

6. Investor Sentiment and Market Liquidity

Investor sentiment plays a vital role in determining the Pharmeasy unlisted share price. Unlike listed shares, unlisted shares are not traded on a stock exchange, which makes them less liquid. This limited liquidity can lead to higher price volatility, as even small shifts in investor sentiment can result in significant price changes.

Positive news, such as strong financial performance or successful acquisitions, can drive up demand for Pharmeasy unlisted shares, pushing the price higher. Conversely, negative news or market uncertainty can dampen investor sentiment and lead to a decline in the unlisted share price. Understanding market dynamics and staying informed about the company’s developments are essential for making informed investment decisions.

Conclusion

The Pharmeasy unlisted share price is influenced by various factors, including the company’s performance, industry trends, the potential for an IPO, strategic partnerships, the regulatory environment, and investor sentiment. As Pharmeasy continues to expand its operations and strengthen its market position, the demand for its unlisted shares is likely to remain high. However, investors should carefully consider all these factors and conduct thorough research before making investment decisions.

For those looking to stay updated on Pharmeasy unlisted share prices and other unlisted stock opportunities, DelistedStocks is your go-to resource for expert insights and the latest market trends.

[isupportonlinedoctor]

Gotodoctor Welcomes Andrew Duckman as Senior Advisor

Gotodoctor.ca is pleased to welcome Andrew Duckman to its organization as Senior Advisor to the CEO office. 

Andrew Duckman is a trusted corporate development and investment advisor with an entrepreneurial spirit. Over his 20+ year career, Andrew has worked from the ground up and developed top-tier relationships with some of the most influential investors and companies across the country. Most recently with Fort Capital, Echelon Wealth Partners and Bloom Burton & Co, Andrew’s experience spans several sectors, including healthcare, healthcare technology and financial services, with a focus on providing strategic counsel and guidance to companies whose values align with his own.

“Gotodoctor.ca’s is a one-of-a-kind digital healthcare platform at the forefront of disrupting the primary care delivery market,” said Andrew Duckman. “This opportunity aligns perfectly with my interest in healthcare and I am eager to make a meaningful impact along with the Gotodoctor.ca team’s mission of enhancing access to care for Canadians, while aligning with the public healthcare system.” 

“Andrew has a wealth of experience in healthcare, insurance, and capital markets,” said Tommy Cheung, CEO of Gotodoctor.ca. “We look forward to drawing on his expertise and insights to accelerate the growth of Gotodoctor to its next stage.”

About Gotodoctor.ca

Gotodoctor.ca is a leading B2B healthcare technology platform that connects to an estimated a million Canadians through its unique Service Engine and hybrid primary care network. If you are looking for booking doctor appointment in Saskatchewan, then get in touch with Gotodoctor.ca

The platform integrates virtual care and in-person pharmacy and clinic Service Sites, and enables members to access comprehensive and scalable physician and other healthcare services. Gotodoctor.ca is a preferred provider for McKesson Canada’s Rexall and Retail Banner Group (IDA, Guardian, Remedy’s Rx) pharmacies. Its Digital Employee Services and Data Offerings technologies are already adopted and are utilized by major Canadian Enterprises, TPAs, and other enterprises, like Manitoba Blue Cross, Novartis Canada, SEB Administrative Services/Co-Operators, The Leslie Group, Quick Health Access, Simply Benefits, and Automated Administration Services.

[digitrenndsamr]

Wearable Payment Devices Market Will See Strong Expansion Through 2031

Allied Market Research, titled, “Wearable Payment Devices Market," The wearable payment devices market size was valued at $47.1 billion in 2021, and is estimated to reach $158.8 billion by 2031, growing at a CAGR of 13.3% from 2022 to 2031.

Some of the prime drivers of the wearable payment devices industry are surge in penetration of contactless payment systems at various retail stores, petrol pump stations, and restaurants, thereby positively impacting the growth of the wearable payment devices market trends. In addition, the increase in shift from traditional payment systems to digital system across developing nations and rise in the trend of mobile commerce across the globe boost the global wearable payment devices market growth. These transactions are considered highly authenticated and extremely protected as NFC chips interchange cryptographic data to render the transfer complete. However, battery drain issues and the high risk of stolen or lost wearables are expected to hamper the market growth. On the contrary, rise in demand for mobile and wearable payment devices among developing nations, such as China, Japan, and India, is expected to offer remunerative opportunities for the expansion of the market during the forecast period.   

Increase in adoption of wearable contactless payment devices and rise in penetration of wearable payment technology have led to the growth of the wearable payment devices market in recent years. Wearable payment devices comprise several devices such as smart watches, fitness trackers, payment wristbands, smart rings, and others. Unlike mobile payments that are done through the internet, NFC payments are carried out in close physical proximity preventing unauthorized access during the transactions.   

The retail & grocery stores segment is expected to garner a significant wearable payment devices market share during the forecast period. This is attributed to the demand for contactless payment service in the retail industry and increase in investment by retail owners for adopting digital payment technology. However, the others segment contributed the largest wearable payment devices market share in 2020, owing to increase in adoption of mobile payment devices among various industries for reducing cash counting time and different types of errors. The growing integration of NFC payment systems in mobile devices has boosted comfort with using contactless cards, and the increasing acceptance of contactless point-of-sale devices is likely to generate development prospects for the market throughout the forecast period.   

Region-wise, the wearable payment devices market was dominated by Asia-Pacific in 2021 and is expected to retain its position during the forecast period. This is attributed to increase in demand among merchants across the U.S. and Canada to use contactless payment technology. However, North America is expected to witness significant growth rate during the forecast period, owing to the penetration of high-speed internet connectivity across developing nations such as U.S. and Canada.    

The wearable payment devices market analysis is based on device type, technology, application, and region. By device type, the market is classified into fitness trackers, smart watches, payment wristbands and smart rings. By technology, it is divided into near-field communication technology (NFC), radio frequency identification (RFID), and QR and Barcode. By application, it is fragmented into retail & grocery stores, entertainment centers, restaurants & bars, and hospitals & pharmacies.  Region-wise, the wearable payment devices market is analyzed across North America (U.S., Canada, and Mexico), Europe (UK, Germany, France, and rest of Europe), Asia-Pacific (China, Japan, India, South Korea, and rest of Asia-Pacific) and LAMEA (Latin America, the Middle East, and Africa).   

Country-wise, the China region holds a significant wearable payment devices market share in the global wearable payment devices market analysis, owing to the presence of prime players. Major organizations and government institutions in this country are intensely putting resources into this global wearable payment devices. These prime sectors have strengthened the wearable payment devices market growth in the region.  

KEY FINDINGS OF THE STUDY 

In 2021, by device type, the fitness trackers segment was accounted for maximum revenue and is projected to grow at a notable CAGR during the forecast period.

By technology, the QR and barcode segment was the highest revenue contributor to the market, with $26,795.0 million in 2021, and is estimated to reach $87,839.3 million by 2031, with a CAGR of 13.02%. 

By application, the retail and grocery stores segment generated the largest revenue to the market,  and is estimated to reach significant growth by 2031, with a CAGR of 13.7%. 

Region-wise, the Asia-Pacific was the highest revenue contributor, accounting for $23,324.3 million in 2021, and is estimated to reach $85,078.2 million by 2031, with a CAGR of 14.23%. 

The wearable payment devices market key players profiled in the report include Apple Inc., Samsung Electronics Co Ltd, Garmin Ltd., Xiaomi Corporation, Google LLC, Visa, Inc., Barclays, PayPal Holdings, Inc., Mastercard Inc., Fitbit (Google), and Tappy Technology Ltd. The market players have adopted various strategies, such as product launches, collaborations & partnerships, joint ventures, and acquisitions to expand their foothold in the wearable payment devices industry. 

[a-shade-of-blue]

Masterlist of Vetted Fundraisers from the Palestinians who directly contacted me (15 - 17 August)

17 August

Ghada Ashraf (@ghada-ashraf-sousi): Ghada is a French teacher. Her daughter Maria has not been able to get vaccinated and complete her treatment because of the genocide. They are trying to evacuate out of Gaza. (https://gofund.me/094016c9) (Vetted by association. @amalashuor (#175 on the verified fundraiser list by el-shab-hussein and nabulsi) has stated that Ghada is her friend, see post here for proof) (17 Aug: LOW FUNDS! Only €155 raised of €30,000 goal (9 donations!).)

Maria (@maria-gaza1): Maria is a pharmacy student from a family of 6. Their home has been destroyed and they are displaced. (https://gofund.me/b297b689)(vetted by association. She's a friend of @/wafaaresh (shared by 90-ghost) and @/mohiy-gaza (shared by 90-ghost). See post here for proof.)

Basel Ayyad (@basel1995s, basel-1995): Basel is 28 years old and from a family of 8. His daughter has suffered from a disease that impacts her growth and sight, and with the lack of medical resources in Gaza, her health is getting worse and she is gradually lodging her eyesight. They are tyring to evacuate out of Gaza and get her the treatment she needs. (https://gofund.me/0e9c79b3) (This campaign is vetted twice(!) by el-shab-hussein and is listed as #214 on the vetted fundraiser list by el-shab-hussein and nabulsi.)

Mohammed Aldeeb (@mohammedaldeeb): Mohammed is a medical professional specializing in emergency care who worked at the Al-Shifa Hospital for years. Both his home and the hospital have been destroyed. He is from a family of four. They have managed to evacuate and are now trying to cover their living expenses in Egypt. (https://gofund.me/8906146e) (vetted by el-shab-hussein and is #212 on the vetted fundraiser spreadsheet by el-shab-hussein and nabulsi.)

Tahani El-Shorbage & Wissam (@weesamshorbaji, @tahanibaby): Tahani studied chemistry and digital marketing and was an assistant professor at a uni that has now been destroyed. Tahani’s children have contracted hepatitis from water pollution. They are trying to evacuate out of Gaza. (https://gofund.me/de78bf6f) ( #112 on the verified fundraiser list vetted by el-shab-hussein and nabulsi. Also promoted by nabulsi here.) (Tahani’s IG: tahani_marketing)

16 August

Karam Al-Madhoun (@karamalmadhoun0): Karam is a 20 year old graphic design student. He is from a family of five. Their house has been destroyed and they are now displaced. They are trying to evacuate to Egypt. (https://gofund.me/903d0086) (#109 on the verified fundraiser list vetted by el-shab-hussein and nabulsi) (his IG: karam_almadhoun7)

Ahmed Abu Al-Rish (@ahmadresh): Ahmed is 19 years old and wishes to study photographic design but was unable to due to the genocide. He and his family’s house has been bombed and they are now displaced. They wish to escape from this genocide. (https://gofund.me/cecba331) (shared by 90-ghost. Ahmad has also been confirmed as @/mohiy-gaza's brother (see post here))

Ahmed Abu Omar (@ahmedabuomar, ): Ahmed and his wife has 3 children: Omar (11), Ibrahim (10) and Ahmed (4). They have been displaced and are trying to evacuate out of Gaza to Egypt. (https://gofund.me/a4e4c8d7) (Shared by apollos-olives, who states that @/ahmedabuomar is a friend of @/ahmedabuyamin (ahmedabuyamin's gfm is listed as #264 on the verified fundraiser list vetted by el-shab-hussein and nabulsi))

Ahed Al-Ankara (@aahed255): Ahed and his wife Maysoon have 3 children: Fatima (9), Iman (6), and Nour (1). Their have been displaced for more than 10 times. They are trying to evacuate out of Gaza. (https://gofund.me/1e35b377) (This campaign has been shared by @/mohammedalanqer, whose gfm is #174 on the verified fundraiser list vetted by el-shab-hussein and nabulsi) (17 Aug: LOW FUNDS! Only €225 raised of €40,000 goal (9 donations))

15 August

Hazem Khalil (@hazempalestine): Hazeem has not been able to see his family who live in Northern Gaza since 2018 due to the difficult situation there. Their home has been destroyed and he is trying to evacuate his family of 7 (including 2 children who are his younger siblings. (https://gofund.me/55f0129e) (vetted by el-shab-hussein. He is also a friend of Bilal-Salah0. Listed as #281 on the verified fundraiser list by el-shab-hussein and nabulsi.)

Lina Zeyad (@lina-zeyad): Lina is an attorney and has 3 sons -  Abdullah, Yazan, Youssef, and a daughter who is married and pregnant. Her youngest son Yousseff has contracted Hepatitis C after having to drink contaminated water. (https://gofund.me/de10f8c6) (vetted by nabulsi.)

Amna Marwan (@gazaway13): Amna is a mother of 3 children: Ahmed(8), Adam (6), and Ayla (4). Their home has been destroyed and they are displaced. They are trying to evacuate out of Gaza. (https://gofund.me/36e10d4b) (#247 on the verified fundraiser list vetted by el-shab-hussein and nabulsi.)

Abdallah Mousa (@abdallahblog0): Abdallah is a 20 years old uni student. He dreams of becoming a doctor. His house and university has been destroyed. He and his family are trying to evacuate out of Gaza. (https://gogetfunding.com/your-help-is-the-only-hope-to-save-abdallah-his-family-from-genocide/) (https://www.paypal.com/paypalme/RawanMous) (shared by 90-ghost.)

Mahmoud Ziad (@mahmoud-ziad): Mahmoud is 24 years old. He has been displaced with elderly mother and father, his brothers, and his brother’s wife. (https://gofund.me/0aaeecea) (shared by 90-ghost)

Abood and Maria (@maria-abood, @abood-gaza2, @maria-abood2): Abood and Maria got married 5 months ago during the war. Maria is currently pregnant. They have been displaced more than 10 times. They are trying to evacuate out of Gaza. (https://gofund.me/7a4d8d0a) (vetted by association. (Maria's husband Abood is the brother of @/mohiy-gaza. See post here. Mohi's gfm has been shared by 90-ghost.))

Ahmed Khader (@ahmedpalestine): Ahmed is in Belgium but his family is still in Gaza. He is trying to evacuate his family of 12, including 8 adults and 4 children under 16 years old. (https://gofund.me/42d81684) (Ahmed's campaign is promoted by Bilal-Salah0. Bilal's campaign is listed as #132 on the verified fundraiser spreadsheet vetted by el-shab-hussein and nabulsi. Bilal's campaign has reached its goal and he has said that he will ensure the legitimacy of the campaigns he promotes (see post here).)

Ayaa Mahmoud (@ayoosh-gaza, her brother:@ahmad-gaza): Ayaa is a 24 years old children’s teacher . She is living with her parents and her 8 siblings. Their home has been destroyed and they are trying to evacuate to Egypt. (https://gofund.me/87a0fa9f) (UNVETTED but seems legit. Here's her IG: ayaa_mahmoud_99.)

Click here for my Masterlist for fundraisers from 13 July - 25 July.

Click here for my Masterlist for fundraisers from 26 July -29 July.

Click here for my Masterlist for fundraisers from 30 July - 1 August.

Click here for my Masterlist for fundraisers from 2 August - 5 August.

Click here for my Masterlist for fundraisers from 6 August - 10 August.

Click here for my Masterlist for fundraisers from 11 August - 14 August.

How does vetting and verification work? See post here.

[heathcareforallworld]

Global Tretinoin Cream Market Insights: Industry Trends and Future Forecast

Introduction

Tretinoin cream, a derivative of vitamin A, is widely recognized for its efficacy in treating acne, fine wrinkles, and other skin-related conditions. Over the past few years, the demand for tretinoin cream has grown significantly, driven by increasing consumer awareness of skincare products and the rising prevalence of skin conditions such as acne and hyperpigmentation. This article explores the size, share, industry trends, and future forecast of the tretinoin cream market, projecting its growth trajectory up to 2032.

Market Size and Share

The global tretinoin cream market has witnessed substantial growth, with a steady increase in demand across various regions. Tretinoin cream Market Size was estimated at 1.36 (USD Billion) in 2023. The Tretinoin Cream Market Industry is expected to grow from 1.44(USD Billion) in 2024 to 2.2 (USD Billion) by 2032. The tretinoin cream Market CAGR (growth rate) is expected to be around 5.48% during the forecast period (2024 - 2032). This growth can be attributed to several factors, including the increasing prevalence of acne, particularly among adolescents and young adults, the expanding geriatric population, and the growing awareness of anti-aging treatments.

The market is segmented into various product types, with strengths ranging from 0.025% to 0.1%. The 0.05% strength remains the most popular due to its balanced efficacy and tolerability, capturing a significant share of the market. In terms of distribution channels, online pharmacies are emerging as a major player, alongside traditional brick-and-mortar pharmacies, due to the convenience they offer and the growing trend of e-commerce in the pharmaceutical sector.

Industry Trends

Several key trends are shaping the tretinoin cream market:

Rising Demand for Anti-Aging Products: Tretinoin cream is widely recognized for its anti-aging properties, making it a popular choice among the aging population seeking to reduce fine lines and wrinkles. This has led to an increased demand for tretinoin-based products, particularly in developed regions like North America and Europe.

Growth in E-Commerce: The shift towards online shopping has significantly impacted the pharmaceutical industry, including the tretinoin cream market. Online platforms offer consumers easy access to tretinoin products, often at competitive prices, driving market growth.

Increasing Awareness of Skincare: With the proliferation of information through social media and other digital platforms, consumers are becoming more educated about skincare. This has led to a growing preference for products like tretinoin cream that offer proven results for conditions like acne, hyperpigmentation, and photoaging.

Technological Advancements in Dermatology: Innovations in dermatological research and formulation technology have led to the development of enhanced tretinoin products with improved efficacy and reduced side effects. This is likely to drive further market growth as consumers seek out more effective treatments.

Regulatory Changes and Approval: The regulatory landscape for tretinoin cream varies across regions, with some countries requiring a prescription and others allowing over-the-counter sales. Changes in regulations, such as the approval of new formulations or strength variations, can significantly impact the market dynamics.

Regional Analysis

The tretinoin cream market is globally segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

North America: Dominates the market due to the high prevalence of acne and the well-established skincare industry. The region's market is further fueled by strong consumer spending on skincare products and the presence of major pharmaceutical companies.

Europe: Also holds a significant market share, driven by the aging population and increasing demand for anti-aging treatments. The regulatory environment in Europe, which varies by country, plays a crucial role in shaping market trends.

Asia-Pacific: Expected to witness the highest growth rate during the forecast period. The rising disposable income, growing awareness of skincare, and the increasing prevalence of skin conditions contribute to the region's market expansion.

Latin America and the Middle East & Africa: These regions are also experiencing growth, albeit at a slower pace, due to increasing awareness and access to skincare products.

Forecast to 2032

The tretinoin cream market is poised for significant growth over the next decade, with a projected CAGR of 5.48% from 2024 to 2032. Several factors will drive this growth:

Continued Demand for Acne Treatments: Acne remains one of the most common skin conditions worldwide, particularly among adolescents and young adults. As awareness of effective treatments like tretinoin cream continues to rise, so will the demand for these products.

Expansion of Anti-Aging Markets: The global anti-aging market is expected to grow substantially, with tretinoin cream playing a key role in this expansion. As more consumers seek to maintain youthful skin, the demand for tretinoin-based products is likely to increase.

Technological Innovations: Advances in dermatological research and product formulation are expected to result in the development of more effective and user-friendly tretinoin products, further driving market growth.

Market Penetration in Emerging Economies: As awareness and access to skincare products improve in emerging economies, these regions are expected to contribute significantly to the market's growth.

Conclusion

The tretinoin cream market is on a strong growth trajectory, driven by increasing consumer awareness, technological advancements, and the rising demand for both acne and anti-aging treatments. With a promising forecast through 2032, the market presents numerous opportunities for growth and innovation. Key players in the industry are likely to continue investing in research and development, new product launches, and strategic partnerships to capitalize on the growing demand and expand their market presence.

[tamanna31]

Pharmacy Market Dynamics, Top Manufacturers Analysis, Trend And Demand, Forecast To 2030

Pharmacy Industry Overview

The global pharmacy market size was estimated at USD 1.26 trillion in 2023 and is expected to grow at a CAGR of 7.28% from 2024 to 2030.

The growing demand for specialty drugs globally and increasing prescription drug expenditure in developed countries are expected to drive the growth of the market over the forecast period. In addition, the growing prevalence of chronic diseases, majorly due to changes in lifestyle and a rapidly aging population, are supplementing the market growth.

The growing demand for prescription medications is contributing to the industry's growth. As the demand for prescription drugs increases, pharmacies experience a surge in business due to the need for dispensing these medications. According to the National Health Service the current cost of an NHS prescription in England for 2024-2025 is USD 12.65 per item, an increase of USD 0.51 from the previous year. Prescription charges are usually reviewed annually. The cost has increased steadily in recent years, from USD 8.80 in 2015 - 2016 to USD 10.47 in 2024 - 2025.

Gather more insights about the market drivers, restrains and growth of the Pharmacy Market

Moreover, pharmacies are adopting digitalization programs to cater to the growing demand from consumers and provide improved accessibility to patients. For instance, CVS Health introduced a Digital Transformation program to personalize the healthcare experience using artificial intelligence, machine learning, data, and analytics. Moreover, in December 2021, the company entered into a partnership with Microsoft to scale up retail personalization and loyalty programs using advanced machine learning, powered by Azure. Such digitalization and automation strategies are anticipated to drive the growth in the industry during the forecast period.

Based on product type, the prescription segment dominated the pharmacy market with the largest revenue share of 81.5% in 2023. The increasing demand for prescription drugs for therapies, such as diabetes, cardiovascular disease, respiratory diseases, antibiotics, blood disorders, and oncology, is driving the growth of the prescription segment. Furthermore, the rising prevalence of long-term health conditions and the expanding elderly demographic are fueling the need for prescription drugs.

According to the IDF Diabetes Atlas, 537 million adults were suffering from diabetes in 2021 globally. The number of adults suffering from diabetes is estimated to increase to 783 million by 2045. Almost 90% of older adults regularly take at least one prescription drug, with many taking multiple medications to manage chronic conditions. This growing need for prescription drugs, especially among the aging population, is expected to significantly drive the growth of the industry in the coming years.

However, the OTC segment is estimated to witness the fastest growth rate during the forecast period. The high growth is due to better cost savings compared to prescription drugs, consumer empowerment in managing minor ailments, a shift toward preventive healthcare, an expanding product range, consumer awareness & education, and the influence of online sales and e-commerce platforms. In addition, the increasing trend of self-medication and conversion of prescription medicines to OTC medications is expected to contribute to the growth of the segment over the forecast period. For instance, in March 2023, the U.S. FDA approved Narcan (4 mg), a naloxone hydrochloride nasal spray, for OTC use. It is the first-ever naloxone product approved to be used OTC

Browse through Grand View Research's Pharmaceuticals Industry Research Reports.

• The global Crohn’s disease therapeutics market size was valued at USD 13.20 billion in 2023 and is projected to grow at a CAGR of 2.7% from 2024 to 2030.

• The global estrogen receptor positive breast cancer treatment market size was estimated at USD 19.8 billion in 2023 and is projected to grow at a CAGR of 7.89% from 2024 to 2030.

Key Pharmacy Company Insights

Companies in the market are implementing diverse strategies such as partnerships, collaborations, mergers & acquisitions, and product development to expand their geographical footprint. CVS Health, Boots Walgreens, Walmart, and Rite Aid Corp. are some major players in the market.

Key Pharmacy Companies:

The following are the leading companies in the pharmacy market. These companies collectively hold the largest market share and dictate industry trends.

CVS Health

Boots Walgreens

Cigna

Walmart

Kroger

Rite Aid Corp.

Lloyd Pharmacy

Well Pharmacy

Humana Pharmacy Solutions

Matsumoto Kiyoshi

Apollo Pharmacy

MedPlusMart.com

Recent Developments

In January 2024, Kroger extended its partnership with Centene Corporation's pharmacy network. This extension aimed to provide patients with increased opportunities to save on essential prescriptions. The agreement ensured continued access to the Kroger Family of Pharmacies for approximately 700,000 Centene members in 2024.

In April 2023, Rite Aid Corp launched a new three Rite Aid Pharmacies in Craigsville, Greenville, and Scottsville, Virginia. This initiative was part of a pilot program aimed at enhancing access to services in “pharmacy deserts” and underserved communities.

In February 2022, Medicure Inc. subsidiary Marley Drug Pharmacy in the U.S. introduced its national direct-to-consumer ePharmacy platform, which allows Americans to purchase FDA-approved medications at reduced prices and receive home delivery across all 50 states.

In January 2021, AmerisourceBergen and Walgreens Boots Alliance established a strategic partnership. AmerisourceBergen acquired Walgreens Boots Alliance's Healthcare Business, allowing Walgreens Boots Alliance to enhance its emphasis on expanding its retail operations. This collaboration involves extending and broadening their commercial agreements.

Order a free sample PDF of the Pharmacy Market Intelligence Study, published by Grand View Research.